Healthcare


 Nyrada Strengthens Innovation Push With Xolatryp Patent Progress

Nyrada Strengthens Innovation Push With Xolatryp Patent Progress

May 19, 2026 06:23 PM AEST| By Sam

Nyrada strengthens its biotechnology portfolio after securing a key US patent milestone for Xolatryp, supporting long-term innovation in cardiac therapy research and expanding industry attention.

 Island Pharmaceuticals Builds Momentum in Antiviral Space

Island Pharmaceuticals Builds Momentum in Antiviral Space

May 19, 2026 05:26 PM AEST| By Sam

Island Pharmaceuticals continues strengthening its antiviral development strategy while maintaining financial flexibility, placing the biotechnology company in focus among healthcare market watchers.

 BCAL Diagnostics Broadens Early Detection Reach Across Australia

BCAL Diagnostics Broadens Early Detection Reach Across Australia

May 19, 2026 04:18 PM AEST| By Sam

BCAL Diagnostics is advancing early cancer detection access through national GP integration, telehealth support, and expanded healthcare infrastructure across Australia and global markets.

 Pro Medicus Strengthens US Expansion With New Imaging Agreement

Pro Medicus Strengthens US Expansion With New Imaging Agreement

May 19, 2026 04:06 PM AEST| By Sam

Pro Medicus strengthens its US healthcare footprint with a major cloud imaging agreement, highlighting growing demand for advanced medical technology solutions across global healthcare networks.

 Oil Shock and Banking Drag Sink Australian Shares

Oil Shock and Banking Drag Sink Australian Shares

May 19, 2026 03:36 PM AEST| By Sam

Australian shares weakened as rising oil prices, geopolitical tensions, and heavy selling in banking and healthcare stocks triggered cautious sentiment across multiple sectors.

 Market Rebound Sparks Fresh Confidence Across Australian Shares

Market Rebound Sparks Fresh Confidence Across Australian Shares

May 19, 2026 03:28 PM AEST| By Sam

Australian shares rebounded after recent market weakness as retail, healthcare, insurance, and industrial stocks regained momentum, while mining companies remained under pressure amid softer oil prices and easing geopolitical concerns.

 Why These Australian Shares Are Back in the Spotlight

Why These Australian Shares Are Back in the Spotlight

May 19, 2026 03:08 PM AEST| By Sam

Australian healthcare, gold and consumer-focused shares are regaining momentum as market sentiment improves and investors reassess long-term growth sectors across the local equities landscape.

 Why These Beaten-Down ASX Shares Are Turning Heads

Why These Beaten-Down ASX Shares Are Turning Heads

May 19, 2026 02:54 PM AEST| By Sam

Several heavily sold-down Australian shares rebounded as market sentiment improved, though ongoing economic pressure, regulation, and global uncertainty continue shaping the recovery outlook across healthcare, retail, industrial, and wagering sectors...

 Lithium Stock Roars Back as Woolworths Leads Market Charge

Lithium Stock Roars Back as Woolworths Leads Market Charge

May 19, 2026 02:19 PM AEST| By Sam

Australian shares advanced as supermarket stocks gained favour and lithium optimism returned after Mineral Resources restarted a major mine, while gold, healthcare and technology sectors delivered mixed market reactions.

 Alcidion’s Healthcare Expansion Signals Digital Growth

Alcidion’s Healthcare Expansion Signals Digital Growth

May 18, 2026 05:49 PM AEST| By Sam

Alcidion expands its healthcare technology capabilities through a strategic acquisition, enhancing patient flow solutions, customer reach, and cloud-based healthcare innovation across Australia.

 Why Pro Medicus Is Defying the Market Mood

Why Pro Medicus Is Defying the Market Mood

May 18, 2026 04:23 PM AEST| By Sam

Pro Medicus drew attention after securing a major healthcare imaging agreement in North America, reinforcing confidence around digital healthcare infrastructure and cloud-based enterprise imaging technology despite broader market weakness.

 Why Pro Medicus Has the Market Watching Closely

Why Pro Medicus Has the Market Watching Closely

May 18, 2026 03:45 PM AEST| By Sam

Pro Medicus has strengthened its global healthcare technology presence through another major imaging agreement, highlighting rising demand for cloud-based medical infrastructure and enterprise diagnostic platforms.

 Why This Hearing Giant’s Slump Is Turning Heads

Why This Hearing Giant’s Slump Is Turning Heads

May 18, 2026 03:29 PM AEST| By Sam

Cochlear’s recent market decline has shifted attention toward its long-term healthcare strengths, specialised hearing technology, and growing global treatment demand despite softer market sentiment.

 ASX 20 Healthcare Giant Draws Attention After Sharp Share Price Slide

ASX 20 Healthcare Giant Draws Attention After Sharp Share Price Slide

May 18, 2026 10:56 AM AEST| By Sam

CSL remains under strong investor focus as biotechnology growth, healthcare demand, and defensive earnings themes continue shaping market sentiment.

 ASX 200 Healthcare Share Faces Pressure After Guidance Reset

ASX 200 Healthcare Share Faces Pressure After Guidance Reset

May 18, 2026 10:20 AM AEST| By Sam

Healius remains under market scrutiny as labour cost inflation, healthcare funding pressures, and operational restructuring reshape sentiment around the healthcare provider.

 Could Integral Diagnostics ASX 300 Stay In Focus?

Could Integral Diagnostics ASX 300 Stay In Focus?

May 18, 2026 10:19 AM AEST| By Sam

Integral Diagnostics remained under healthcare market attention as diagnostic imaging demand, connected healthcare systems and digital patient support platforms continued shaping Australia’s medical technology sector.

 Could ResMed ASX 200 Healthcare Strength Continue?

Could ResMed ASX 200 Healthcare Strength Continue?

May 17, 2026 05:33 PM AEST| By Sam

ResMed remained under healthcare market attention as respiratory treatment systems, sleep care technologies and connected healthcare platforms continued shaping Australia’s medical technology sector.

 Radiopharm Theranostics Draws Attention After Insider Buying

Radiopharm Theranostics Draws Attention After Insider Buying

May 17, 2026 10:46 AM AEST| By Sam

Radiopharm Theranostics continues attracting market attention as insider buying activity and growing interest in precision oncology shape sentiment around the emerging healthcare company.

 Why Cochlear Is Quietly Regaining Market Attention

Why Cochlear Is Quietly Regaining Market Attention

May 17, 2026 10:43 AM AEST| By Sam

Cochlear continues attracting investor attention as healthcare stocks regain momentum through defensive demand trends, ageing population exposure, and long-term medical technology growth themes.

 Why ResMed Shares Are Back in Focus Amid Healthcare Technology Shifts

Why ResMed Shares Are Back in Focus Amid Healthcare Technology Shifts

May 16, 2026 01:15 PM AEST| By Sam

ResMed and QBE are drawing renewed attention as healthcare technology adoption, ageing populations, and financial resilience continue shaping long-term ASX market trends.

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.